Federico Abascal
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 2
-
- Scientific Computing and Data Management 1
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Federico Abascal
5 papers receiving 3.4k citations
Federico Abascal's Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 1.7k
- Oncology 844
- Pathology and Forensic Medicine 503
- Molecular Biology 1.7k
- Genetics 469
Countries citing papers authored by Federico Abascal
This map shows the geographic impact of Federico Abascal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Abascal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Abascal more than expected).
Fields of papers citing papers by Federico Abascal
This network shows the impact of papers produced by Federico Abascal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Abascal. The network helps show where Federico Abascal may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 2 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 3 | 2020 | 301 | |
| 4 | 2020 | 39 | |
| 5 | 2020 | 9 |
About Federico Abascal
Federico Abascal is a scholar working on Cancer Research, Information Systems and Management, Statistics and Probability, Molecular Biology and Pathology and Forensic Medicine, having authored 5 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Statistical Methods in Clinical Trials (1 paper), Genomics and Phylogenetic Studies (1 paper), Gene expression and cancer classification (1 paper), Scientific Computing and Data Management (1 paper), RNA modifications and cancer (1 paper), Evolution and Genetic Dynamics (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (844 citations), Pathology and Forensic Medicine (503 citations), Molecular Biology (1.7k citations) and Genetics (469 citations). Federico Abascal has collaborated with scholars based in Germany, United Kingdom and United States. Their work appears in journals such as Nature, Nature Communications and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.